Skip to main content
. 2020 Nov 16;34(4):414–425. doi: 10.1093/ajh/hpaa176

Table 1.

Characteristics of the study participants at baseline, according to estimated sodium excretion (conditional analysis)

Characteristic Case Control
Estimated sodium excretion
All <2.8 g/day 2.8–3.5 g/day 3.5–4.3 g/day >4.3 g/day All <2.8 g/day 2.8–3.5 g/day 3.5–4.3 g/day >4.3 g/day
(N = 8,761) (N = 2,214) (N = 1,911) (N = 2,065) (N = 2,571) (N = 8,767) (N = 2,075) (N = 2,481) (N = 2,352) (N = 1,859)
Estimated excretion, g/day
 Sodium 3.69 ± 1.28 2.23 ± 0.44 3.19 ± 0.20 3.88 ± 0.21 5.18 ± 1.02 3.54 ± 1.04 2.32 ± 0.41 3.19 ± 0.20 3.88 ± 0.21 4.93 ± 0.93
 Potassium 1.58 ± 0.38 1.43 ± 0.30 1.49 ± 0.33 1.56 ± 0.34 1.78 ± 0.42 1.68 ± 0.42 1.48 ± 0.35 1.62 ± 0.39 1.75 ± 0.40 1.88 ± 0.44
Age, year 62.9 ± 13.4 63.9 ± 13.7 63.0 ± 13.4 62.5 ± 13.2 62.3 ± 13.2 62.1 ± 13.2 63.7 ± 13.5 62.0 ± 13.2 61.3 ± 12.9 61.5 ± 13.0
Female sex, no. (%) 3,574 (40.8) 959 (26.8) 770 (21.5) 797 (22.3) 1,048 (29.3) 3,580 (40.8) 925 (25.8) 978 (27.3) 929 (25.9) 748 (20.9)
Geographic region, no. (%)
 Western Europe/North America 1,544 (17.6) 567 (36.7) 394 (25.5) 302 (19.6) 281 (18.2) 1,544 (17.6) 381 (24.7) 439 (28.4) 447 (29.0) 277 (17.9)
 Eastern/Central Europe/ Middle East 1,079 (12.3) 206 (19.1) 213 (19.7) 290 (26.9) 370 (34.3) 1,079 (12.3) 211 (19.6) 287 (26.6) 322 (29.8) 259 (24.0)
 Africa 587 (6.70) 278 (47.4) 126 (21.5) 90 (15.3) 93 (15.8) 587 (6.70) 213 (36.3) 192 (32.7) 118 (20.1) 64 (10.9)
 China 3,891 (44.4) 728 (18.7) 836 (21.5) 1,053 (27.1) 1,274 (32.7) 3,891 (44.4) 832 (21.4) 1,089 (28.0) 1,051 (27.0) 919 (23.6)
 South East Asia 615 (7.02) 155 (25.2) 123 (20.0) 125 (20.3) 212 (34.5) 615 (7.01) 204 (33.2) 214 (34.8) 126 (20.5) 71 (11.5)
 South America 1,045 (11.9) 280 (26.8) 219 (21.0) 205 (19.6) 341 (32.6) 1,051 (12.0) 234 (22.3) 260 (24.7) 288 (27.4) 269 (25.6)
Stroke type, no. (%)
 Ischemic 6,805 (77.7) 1,710 (77.4) 1,537 (81.0) 1,646 (80.0) 1,912 (74.7)
 ICH 1,919 (21.9) 499 (22.6) 361 (19.0) 411 (20.0) 648 (25.3)
Hypertension, no. (%) 5,243 (59.8) 1,363 (61.6) 1,134 (59.3) 1,192 (57.7) 1,554 (60.4) 3,299 (37.6) 974 (46.9) 998 (40.2) 988 (42.0) 856 (46.0)
Blood pressure, mm Hg
 Systolic 148 ± 21.2 149 ± 22.0 147 ± 20.8 148 ± 20.5 149 ± 21.3 133 ± 18.5 133 ± 19.1 133 ± 18.3 133 ± 17.8 134 ± 18.7
 Diastolic 86.5 ± 12.3 87.0 ± 13.2 85.4 ± 12.1 86.5 ± 11.8 86.9 ± 12.0 80.1 ± 10.7 79.3 ± 11.2 79.8 ± 10.5 80.3 ± 10.3 81.1 ± 10.6
Cholesterol, mmol/l
 HDL 1.15 ± 0.35 1.18 ± 0.37 1.16 ± 0.37 1.14 ± 0.34 1.12 ± 0.33 1.22 ± 0.37 1.22 ± 0.38 1.23 ± 0.38 1.21 ± 0.35 1.20 ± 0.37
 LDL 2.97 ± 1.01 3.03 ± 1.08 2.96 ± 0.98 2.99 ± 0.99 2.91 ± 0.98 2.98 ± 0.96 2.98 ± 1.01 3.04 ± 0.97 2.97 ± 0.94 2.90 ± 0.92
Diabetes mellitus, no. (%) 1,486 (17.0) 355 (16.0) 315 (16.5) 359 (17.4) 457 (17.8) 1,108 (12.6) 283 (13.6) 304 (12.3) 303 (12.9) 218 (11.7)
AFIB/atrial flutter, no. (%) 936 (10.7) 301 (13.6) 210 (11.0) 170 (8.23) 255 (9.92) 270 (3.08) 74 (3.57) 69 (2.78) 61 (2.59) 66 (3.55)
Diuretic preadmission, no. (%) 1,132 (12.9) 298 (13.5) 260 (13.6) 229 (11.1) 345 (13.4) 782 (8.92) 194 (9.35) 185 (7.46) 204 (8.68) 199 (10.7)
Diuretic in hospital, no. (%) 1,994 (22.8) 537 (24.3) 418 (21.9) 441 (21.4) 598 (23.3) 352 (12.8) 73 (11.3) 80 (10.2) 95 (13.7) 104 (16.3)
Current smoker, no. (%) 2,623 (29.9) 610 (27.6) 591 (30.9) 666 (32.3) 756 (29.4) 1,850 (21.1) 429 (20.7) 522 (21.0) 510 (21.7) 389 (20.9)

Abbreviations: AFIB, atrial fibrillation; HDL, high-density lipoprotein; ICH, intracerebral hemorrhage; LDL, low-density lipoprotein.